Top Markets
#1 MowCat MowCat +26.51%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +17.74%
#3 Versatize Coin Versatize Coin +16.66%
#4 QuantixAI QuantixAI +14.43%
#5 Pons Pons +13.72%
#6 OriginTrail OriginTrail +13.50%
#7 Wrapped NXM Wrapped NXM +10.25%
#8 Collector Crypt Collector Crypt +8.37%
#9 Siren Siren +8.14%
#10 DAPPOS DAPPOS +7.09%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc.

ZIOP
Rank in Stocks #20771
ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to... ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing innovative immuno-oncology treatments for cancer patients. The company leverages its proprietary Sleeping Beauty platform, which employs non-viral genetic engineering to modify T-cells outside the body using a transposon/transposase system for subsequent infusion. Additionally, ZIOPHARM is advancing its Controlled IL-12 technology, designed to precisely regulate the expression of interleukin-12 (IL-12), a key immune system regulator, to direct the patient's immune response against cancer cells. Its pipeline features several promising therapeutic candidates, including T-cell receptor (TCR) plus T-cell therapies aimed at solid tumors, chimeric antigen receptor (CAR) T-cell therapies specifically targeting CD19 for hematologic malignancies, and Ad-RTS-hIL-12 combined with veledimex, a gene delivery system for controlled IL-12 production under investigation for treating recurrent adult glioblastoma multiforme. ZIOPHARM maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., and research and development agreements, alongside patent licensing, with institutions such as The University of Texas MD Anderson Cancer Center and the National Cancer Institute. The company's headquarters are located in Boston, Massachusetts.
Share Price
$0.8657
Last synced: 2022-01-26
Market Cap
$122.22M
Change (1 day)
-0.88%
Change (1 year)
0.00%
Country
US
Trade ZIOPHARM Oncology, Inc. (ZIOP)

Category

Healthcare
Number of shares outstanding for ZIOPHARM Oncology, Inc. (ZIOP)
Number of shares outstanding as of August 2026: 0
According to ZIOPHARM Oncology, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for ZIOPHARM Oncology, Inc. (ZIOP) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH